A long-acting regulatory research peptide supplied as a laboratory-prepared pen

Cagrilinitide 10 mg from SEMPICA HEALTHCARE is supplied as a pre-mixed, laboratory-prepared research product, presented in a sealed pen format to ensure clarity, consistency, and ease of handling for analytical and laboratory work.

This product is sold strictly for research and development purposes only. It is not a medicine, not a treatment, and not supplied with instructions, protocols, or advice. By purchasing, you accept full responsibility for how the product is stored, handled, and used within your own research environment.

What Cagrilinitide Is (Clear, Plain Explanation)

Cagrilinitide is a synthetic peptide analogue that has been developed and studied because of its long-acting interaction with metabolic signalling systems. In simple terms, it is of interest to researchers because it remains active in signalling models for longer periods than many shorter-acting peptides.

This extended activity profile makes Cagrilinitide useful in research that focuses on signal duration, pathway persistence, and comparative behaviour over time, rather than short, isolated responses.

Why Cagrilinitide Is Studied

Cagrilinitide has been widely studied in metabolic and weight-related research models, often alongside other peptides, because of its ability to influence signalling systems linked to appetite and energy regulation.

Published research has reported strong outcomes in metabolic and weight-loss studies, which has made Cagrilinitide a frequent subject of academic discussion and ongoing investigation.

These findings are referenced here only to explain scientific and research interest.
They do not relate to this product being sold and do not imply any outcome, effect, or intended use.

SEMPICA HEALTHCARE does not sell Cagrilinitide for weight loss, metabolic treatment, or human application.

Research Areas of Interest

In laboratory and analytical environments, Cagrilinitide is commonly studied to explore:

• Appetite-related signalling pathways
• Long-acting peptide behaviour
• Signal persistence over extended timeframes
• Interaction with complementary metabolic peptides
• Differences between short-acting and long-acting compounds

All research involving this product is observational and investigative, not clinical or applied.

Why a 10 mg Format Is Used in Research

The 10 mg format is often selected for:

• Targeted signalling studies
• Comparative research alongside other peptides
• Combination or blend-based research models
• Short-to-medium duration observation

This format allows researchers to work with a defined, manageable quantity while maintaining consistency across studies.

Why SEMPICA Uses a Pre-Prepared Pen Format

Many peptide suppliers sell Cagrilinitide as a dry powder in a vial, requiring the buyer to decide how it should be prepared. This introduces variation before research even begins.

SEMPICA HEALTHCARE supplies Cagrilinitide 10 mg as:

• A laboratory-prepared liquid solution
• Pre-mixed in a fixed volume of bacteriostatic water
• Supplied in a sealed precision pen
• Clearly labelled with known content and volume

This approach removes preparation guesswork and supports repeatable research conditions.

Technical Information

Compound name: Cagrilinitide
Category: Long-acting regulatory peptide analogue
CAS number: 1863516-44-0
Molecular weight: Approximately 4,500 Da
Purity: ≥ 99 %

Net content: 10 mg
Solvent: 3 ml bacteriostatic water
Appearance: Clear liquid
Solution colour: Clear
Format: Factory-sealed research pen

This information is provided so purchasers know exactly what the compound is.

What Is Included

Each Cagrilinitide 10 mg Research Pen System includes:

• One pre-mixed Cagrilinitide 10 mg research pen
• Individually sealed microneedles (for research handling only)
• Alcohol swabs
• Printed storage and handling notes

No usage instructions, plans, or research protocols are supplied.

Storage and Preservation Notes

• Store refrigerated when not in use
• Do not freeze
• Avoid direct or indirect sunlight
• Keep sealed when not being handled
• Inspect visually; solution should remain clear

These notes are provided solely to help preserve material integrity.

Related Research Products

Cagrilinitide is often purchased alongside other research peptides to explore broader metabolic signalling behaviour. Commonly paired products include:

• Tirzepatide
• Retatrutide
• Semaglutide
• MOTS-C
• AOD-9604

SEMPICA HEALTHCARE does not advise on combinations. Any such decisions are entirely the responsibility of the purchaser.

Why Researchers Choose SEMPICA HEALTHCARE

Many short-term peptide websites focus on selling vials with minimal explanation and little accountability.

SEMPICA HEALTHCARE focuses on:

• Clearly defined research materials
• Laboratory-prepared solutions
• Consistent presentation and labelling
• Information that explains the compound, not how to use it

We supply the product.
What you do with it is your responsibility.

Important Notice – Please Read

This product is supplied strictly for research and development purposes only.

It is not intended to:

• Diagnose, treat, cure, or prevent any disease
• Be used on or by humans or animals
• Be sold or represented as a medicine, supplement, or injectable product

SEMPICA HEALTHCARE provides no guidance, plans, protocols, or advice beyond the information published on this page.
By purchasing, you confirm that you accept full responsibility for use, storage, handling, and legal compliance.

Buy Cagrilinitide 10 mg Research Pen